New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
06:08 EDTKOS, XOM, CIE, BP, KKR, CVX, RDS.AOn the Fly: Periodicals Wrap-Up
WALL STREET JOURNAL: Shipping some of the newly abundant U.S. natural gas overseas would benefit the nation's economy more than keeping it all at home, according to a long-awaited study by the Energy Information Administration, which has the potential to reshape the global energy market. The endorsement could turn the tide in a politically sensitive issue, the Wall Street Journal reports...Regulators and market analysts say some money managers wait until the last moments of a quarter to bid aggressively for more shares of a stock they already own, which drives up the value of their entire position in the stock. A Wall Street Journal analysis of daily trading in about 10,000 stocks since 2004 found that on the final trading day of each quarter, there was a sharp increase in the number of stocks that beat the market by at least five percentage points, then trailed it by three points or more the next trading day, the Wall Street Journal reports...REUTERS: Apple’s (AAPL) rank in China's smartphone market fell to number six in Q3, or under 10%, as it faces tougher competition from Chinese brands, according to research firm IDC, Reuters reports...The European Central Bank will likely keep interest rates on hold on today but may offer clues on its policy path for next year with updated forecasts likely to present a difficult outlook for the euro zone economy in 2013, Reuters reports...BLOOMBERG: Chevron (CVX), facing its longest slide in energy output in four years, could use its record cash to reignite growth by acquiring Cobalt International Energy (CIE) or Kosmos Energy (KOS), Bloomberg reports...KKR & Co. (KKR) sees investment opportunities in Southeast Asian companies that will benefit from economic growth and increased consumer spending in 2013, Bloomberg reports.
News For A;BP;XOM;CVX;CIE;KOS;KKR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
May 18, 2015
19:12 EDTAOn The Fly: After Hours Movers
Subscribe for More Information
17:15 EDTAAgilent down almost 5% after Q2 earnings results, guidance
16:10 EDTAAgilent sees FY15 EPS $1.67- $1.73, consensus $1.69
Subscribe for More Information
16:07 EDTAAgilent sees Q3 EPS 38c-42c, consensus 42c
Sees Q3 revenue $995M-$1.015B, consensus $1B.
16:06 EDTAAgilent reports Q2 EPS 38c, consensus 39c
Subscribe for More Information
15:00 EDTANotable companies reporting after market close
Subscribe for More Information
10:01 EDTCVX, BPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:36 EDTCVXActive equity options trading on open
Subscribe for More Information
09:20 EDTCVXW.R. Grace, Chevron JV to build catalysts plant in Lake Charles, LA
Subscribe for More Information
08:12 EDTBPBP downgraded to Sell from Neutral at Goldman
Goldman downgraded BP to Sell based on limited upstream growth, a slowdown in asset disposals, and ongoing overhang from Macondo.
07:56 EDTCVX, KOSKosmos provides update on Mauritania drilling
Subscribe for More Information
07:23 EDTCVXChevron downgraded to Sell from Neutral at Goldman
Subscribe for More Information
May 15, 2015
11:08 EDTKKROmega Advisors gives quarterly update on stakes
NEW STAKES: Targa Resources (TRGP), Targa Resources Partners (NGLS), Humana (HUM), Dow Chemical (DOW), and Twenty-First Century Fox (FOXA). INCREASED STAKES: Kinder Morgan (KMI), Chimera Investment Corporation (CIM), AerCap Holdings (AER), Shire (SHPG), and KKR & Co. (KKR). DECREASED STAKES: eBay (EBAY), Altisource Portfolio Solutions (ASPS), Caesars Entertainment (CZR), Navient (NAVI), and TerraForm Power (TERP). LIQUIDATED STAKES: HCA Holdings (HCA), Gilead (GILD), Cabot Oil & Gas (COG), and Apple (AAPL).
09:01 EDTKKRKKR forms JV with Monterra Energy
Subscribe for More Information
08:08 EDTADarwin Professional presents positive clinical data for ALD403
Alder BioPharmaceuticals announced that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide, or CGRP, antibody for the prevention of frequent episodic migraine, were presented in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain. Key Points from Oral Session: Migraine Pathophysiology and CGRP as a Therapeutic Target: A single intravenous dose of ALD403 1000mg demonstrated prolonged efficacy over six months for the preventive treatment of migraine. Over three months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 61% vs 33%; 33% vs 9%; and 16% vs 0%, respectively. Over six months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 53% vs 28%; 26% vs 7%; and 11% vs 0%, respectively. ALD403 was well tolerated and there were no differences from placebo in terms of adverse events or laboratory safety data. The migraine prevention proof-of-concept trial was conducted in 163 patients with frequent episodic migraine who had on average nine headache days per month. Patients were given a single intravenous dose of 1000mg of ALD403 or placebo. The primary endpoint was the mean change in migraine headache days from baseline to weeks 5-8, and patients were followed for 24 weeks for additional safety and efficacy analyses.
06:44 EDTCVX, XOM, BPEnvironmentalists file lawsuit over oil train safety rules, NY Times says
Subscribe for More Information
May 13, 2015
08:08 EDTAAgilent volatility elevated into Q1 and sales outlook
Subscribe for More Information
May 12, 2015
05:38 EDTBPTechnip awarded lump sum project by BP Exploration & Production
Subscribe for More Information
May 11, 2015
13:28 EDTXOM, CVX, BPOPEC sees oil at around $76 a barrel in 2025, WSJ says
Subscribe for More Information
10:01 EDTXOMExxon Mobil announces Cold Lake project expansion begins production on schedule
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use